Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts

Keyphrases

• Dense Breast 100%
• Breast Cancer Screening 100%
• Dual Head 100%
• Gamma Spectrometry 100%
• Mammography 61%
• 95% Confidence Interval 30%
• Diagnostic Yield 15%
• Risk Factors 7%
• Clinically Significant 7%
• Screening Mammography 7%
• Breast Cancer 7%
• Positive Predictive Value 7%
• Radiation Dose 7%
• Node-negative 7%
• Institutional Review Board 7%
• Patients with Breast Cancer 7%
• Informed Consent 7%
• Cancer Diagnosis 7%
• Performance Characteristics 7%
• 12-month Follow-up 7%
• HIPAA 7%
• Number of Biopsies 7%
• Incremental Risk 7%
• Node-negative Breast Cancer 7%
• Screening Assessment 7%
• Technetium Tc 99m Sestamibi 7%
• As(III) 7%
• Mammography Imaging 7%
• Yield Sensitivity 7%
• Prior Mammograms 7%
• Patient numbers 7%
• Sensitivity/specificity 7%
• Equivalent Performance 7%

Nursing and Health Professions

• Imaging 100%
• Breast Cancer 100%
• Cancer Screening 100%
• Mammography 76%
• Confidence Interval 30%
• Malignant Neoplasm 15%
• Diagnostic Value 15%
• Cancer Diagnosis 7%
• Sensitivity and Specificity 7%
• Injection 7%
• Radiation Dose 7%
• Predictive Value 7%
• Institutional Review 7%
• Biopsy Technique 7%
• Methoxy Isobutyl Isonitrile Technetium Tc 99m 7%
• Technetium-99m 7%
• Consent 7%

Medicine and Dentistry

• Mammography 100%
• Breast Cancer Screening 100%
• Breast Cancer 30%
• Malignant Neoplasm 20%
• Sensitivity and Specificity 10%
• Cancer 10%
• Cancer Diagnosis 10%
• Informed Consent 10%
• Injection 10%
• Technetium-99 10%
• Biopsy Technique 10%
• Methoxy Isobutyl Isonitrile Technetium Tc 99m 10%